Southampton scientists begin Phase II patient trial for new asthma treatment
Thursday, April 8, 2010 - 12:08
in Health & Medicine
Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.